Your browser doesn't support javascript.
loading
Maintenance of response to oral octreotide compared with injectable somatostatin receptor ligands in patients with acromegaly: a phase 3, multicentre, randomised controlled trial.
Fleseriu, Maria; Dreval, Alexander; Bondar, Irina; Vagapova, Gulnar; Macut, Djuro; Pokramovich, Yulia G; Molitch, Mark E; Leonova, Nina; Raverot, Gerald; Grineva, Elena; Poteshkin, Yury E; Gilgun-Sherki, Yossi; Ludlam, William H; Patou, Gary; Haviv, Asi; Gordon, Murray B; Biermasz, Nienke R; Melmed, Shlomo; Strasburger, Christian J.
Afiliación
  • Fleseriu M; Pituitary Center, Department of Medicine (Division of Endocrinology, Diabetes and Clinical Nutrition) and Department of Neurological Surgery, Oregon Health & Science University, Portland, OR, USA. Electronic address: fleseriu@ohsu.edu.
  • Dreval A; Department of Clinical Endocrinology of Postgraduate Education Faculty, M F Vladimirsky Moscow Regional Research Clinical Institute, Moscow, Russia.
  • Bondar I; Department of Endocrinology, Novosibirsk State Medical University, Novosibirsk, Russia.
  • Vagapova G; Department of Endocrinology, Kazan State Medical Academy, Kazan, Russia.
  • Macut D; Department of Endocrine Tumors and Hereditary Cancer Syndromes, Clinic for Endocrinology, Diabetes and Metabolic Diseases, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
  • Pokramovich YG; Department of Clinical Endocrinology of Postgraduate Education Faculty, M F Vladimirsky Moscow Regional Research Clinical Institute, Moscow, Russia.
  • Molitch ME; Endocrinology, Metabolism & Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Leonova N; Clinical Research Department, Endocrinology, Antrium Multidisciplinary Medical Clinic, Barnaul, Altai Region, Russia.
  • Raverot G; Department of Endocrinology, Hospices Civils de Lyon, Bron, France.
  • Grineva E; Endocrinology Institute, Almazov National Medical Research Centre, Petersburg, Russia.
  • Poteshkin YE; Department of Endocrinology, Pirogov Russian National Research Medical University, Moscow, Russia.
  • Gilgun-Sherki Y; Chiasma Inc, Needham, MA, USA, acquired by Amryt Pharmaceuticals DAC, Dublin, Ireland as of August, 2021.
  • Ludlam WH; Recordati Rare Diseases, Lebanon, NJ, USA.
  • Patou G; Chiasma Inc, Needham, MA, USA, acquired by Amryt Pharmaceuticals DAC, Dublin, Ireland as of August, 2021.
  • Haviv A; Chiasma Inc, Needham, MA, USA, acquired by Amryt Pharmaceuticals DAC, Dublin, Ireland as of August, 2021.
  • Gordon MB; Allegheny Neuroendocrinology Center, Allegheny General Hospital, Pittsburgh, PA, USA.
  • Biermasz NR; Division of Endocrinology, Leiden University Medical Center, Leiden, Netherlands.
  • Melmed S; Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Strasburger CJ; Department of Endocrinology and Metabolism, Charite-Universitätsmedizin, Campus Mitte, Berlin, Germany.
Lancet Diabetes Endocrinol ; 10(2): 102-111, 2022 02.
Article en En | MEDLINE | ID: mdl-34953531
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Acromegalia / Hormona de Crecimiento Humana Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Revista: Lancet Diabetes Endocrinol Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Acromegalia / Hormona de Crecimiento Humana Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Revista: Lancet Diabetes Endocrinol Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido